Abstract P113 – Table 1. Soluble markers

	Patients under triple therapy, N = 24 (1)	Patients after 24 weeks dual therapy, N = 12 (2)	Patients after 48 weeks dual therapy, N = 32 (3)	1 vs. 2 p value	2 vs. 3 p value	1 vs. 3 p value
IL6 (pg/mL)	3.23 (1.71 to 4.85)	3.24 (1.90 to 12,0)	1.45 (0.96 to 4.17)	0.585	0.010	0.009
IP10 (pg/mL)	229 (135 to 298)	342 (131 to 432)	139 (46 to 291)	0.280	0.021	0.060
hs‐CRP (mg/L)	1.37 (0.58 to 1.90)	1.17 (0.66 to 2.01)	1.31 (0.63 to 2.25)	0.804	0.969	0.817
sCD14 (pg/mL)	4.40 (4.17 to 4.98)	4.43 (4.20 to 4.64)	4.05 (3.39 to 4.34)	0.518	0.008	<0.001
sCD163 (pg/mL)	626 (490 to 802)	506 (415 to 937)	511 (238 to 726)	0.631	0.442	0.141
D‐dimer (µg/mL)	1.72 (1.53 to 1.91)	1.80 (1.59 to 2.01)	1.83 (1.53 to 2.08)	0.497	0.948	0.380